Target intelligence / Profile preview

CREB3L2 antisense RNA 1 (CREB3L2-AS1)

Target
CREB3L2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

CREB3L2 antisense RNA 1 (CREB3L2-AS1) is a long non-coding RNA (lncRNA) classified as an antisense transcript located on the opposite strand of the CREB3L2 gene. Antisense RNAs are defined as RNAs that are transcribed from the opposite DNA strand at the same genomic locus as a protein-coding gene. However, CREB3L2-AS1 itself does not encode a protein and is not considered a therapeutic target such as a receptor, enzyme, or transporter. The specific biological function, disease associations, and therapeutic relevance of CREB3L2-AS1 remain unclear due to a lack of detailed characterization in publicly available scientific literature. Extensive literature focuses on the protein-coding gene CREB3L2, a transcription factor involved in ER stress response, translation regulation, and cancer biology, but not on this antisense RNA variant. There is no evidence suggesting that CREB3L2-AS1 is currently considered a direct therapeutic target or has approved drugs, known biomarkers, or safety concerns. If a query pertains instead to the protein-coding gene "CREB3L2" (adenosine 3′,5′-monophosphate response element–binding protein 3-like protein 2), that is a validated transcription factor involved in cancer progression and ER stress responses.

Other names
CREB3L2-AS1
02

Biological functions

Unknown (insufficient information available)
03

Disease associations

Unknown (insufficient information available)

Beyond the preview

Go deeper on CREB3L2 antisense RNA 1 (CREB3L2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CREB3L2 antisense RNA 1 (CREB3L2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call